NKGen Biotech, Inc. - NKGN

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2024 · Q3 2024
Value (USD)
Total reported value ($000)
$2.326M
QoQ value delta ($000)
+$1.856M (+394.89%)
Implied price effect (QoQ)
+107.93%
Shares
Total shares
4,179,352
QoQ shares delta
+2,423,370 (+138.01%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NKGN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2024)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Pathstone Holdings, LLC 1,833 2,797,661 0.01%
VANGUARD GROUP INC 149 227,804 0.0%
Sequoia Financial Advisors, LLC 102 156,000 0.0%
Magnetar Financial LLC 95 267,508 0.0%
GEODE CAPITAL MANAGEMENT, LLC 83 127,168 0.0%
XTX Topco Ltd 22 33,625 0.0%
NORTHERN TRUST CORP 19 29,082 0.0%
TWO SIGMA INVESTMENTS, LP 14 22,356 0.0%
STATE STREET CORP 7 11,200 0.0%
Tower Research Capital LLC (TRC) 1 2,782 0.0%
BlackRock, Inc. 1 1,854 0.0%
JPMORGAN CHASE & CO 0 45 0.0%
BANK OF AMERICA CORP /DE/ 0 102 0.0%
Polar Asset Management Partners Inc. 0 500,000 0.0%
UBS Group AG 0 763 0.0%
SBI Securities Co., Ltd. 0 902 0.0%
Federation des caisses Desjardins du Quebec 0 500 0.0%